CN Stock MarketDetailed Quotes

600976 Jianmin Pharmaceutical Group

Watchlist
  • 43.04
  • +0.16+0.37%
Market Closed Nov 1 15:00 CST
6.60BMarket Cap15.43P/E (TTM)

Jianmin Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jianmin Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.116B--
--2024/FY-- / 4.590B--
Mar 16, 20242023/FY4.213B / 4.262B--
Mar 15, 20232022/FY3.641B / 3.909B--
Mar 18, 20222021/FY3.278B / 3.228B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.116B--
--2024/FY-- / 4.590B--
Mar 16, 20242023/FY4.213B / 4.262B--
Mar 15, 20232022/FY3.641B / 3.909B--
Mar 18, 20222021/FY3.278B / 3.228B--

Unlock Free Earnings Estimates

Jianmin Pharmaceutical Group Earnings Reports

  • Jianmin Group Report for the Third Quarter of 2024

    Oct 18 12:00 ET

  • Full text of Jianmin Pharmaceutical Group's 2024 interim report.

    Aug 15 12:00 ET

  • Summary of Jianmin Pharmaceutical Group's H1 2024 report.

    Aug 15 12:00 ET

  • Jianmin Group Report for the First Quarter of 2024

    Apr 19 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 3, 2024

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      15.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data